Waypoint Bio, a biotechnology company pioneering novel cell therapies for solid tumors using in vivo spatial pooled screening technology, announced $14.5 million in seed funding...
Holoclara, a biotechnology company pioneering the development of worm-derived therapies for allergies and autoimmune disorders, announced the completion of an oversubscribed $16 million Series...
Immunome, Inc., a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced the appointment of Phil Tsai, PhD, as Chief Technical...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
